Palla Pharma Ltd
ASX:PAL
Cash Flow Statement
Cash Flow Statement
Palla Pharma Ltd
Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||
Cash Interest Paid |
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Operating Activities |
(16)
N/A
|
(17)
-7%
|
(14)
+16%
|
(16)
-16%
|
(13)
+18%
|
(9)
+31%
|
(15)
-62%
|
(15)
-1%
|
(9)
+36%
|
(8)
+12%
|
(15)
-78%
|
(23)
-54%
|
|
Investing Cash Flow | |||||||||||||
Capital Expenditures |
(10)
|
(6)
|
(4)
|
(3)
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(3)
|
(2)
|
(1)
|
|
Other Items |
3
|
0
|
0
|
0
|
(26)
|
(21)
|
6
|
2
|
0
|
0
|
3
|
3
|
|
Cash from Investing Activities |
(8)
N/A
|
(6)
+28%
|
(4)
+33%
|
(3)
+13%
|
(28)
-759%
|
(23)
+19%
|
3
N/A
|
(2)
N/A
|
(2)
-27%
|
(3)
-39%
|
1
N/A
|
3
+230%
|
|
Financing Cash Flow | |||||||||||||
Net Issuance of Common Stock |
28
|
0
|
4
|
4
|
54
|
54
|
0
|
0
|
31
|
0
|
0
|
17
|
|
Net Issuance of Debt |
(5)
|
17
|
14
|
2
|
(7)
|
(6)
|
10
|
18
|
(17)
|
(18)
|
13
|
2
|
|
Other |
0
|
0
|
0
|
0
|
(3)
|
(3)
|
0
|
0
|
(2)
|
(2)
|
(0)
|
(0)
|
|
Cash from Financing Activities |
23
N/A
|
17
-26%
|
18
+6%
|
29
+61%
|
44
+53%
|
22
-51%
|
10
-56%
|
18
+86%
|
12
-35%
|
11
-7%
|
13
+16%
|
19
+52%
|
|
Change in Cash | |||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
0
N/A
|
(5)
N/A
|
0
N/A
|
10
+2 973%
|
3
-68%
|
(9)
N/A
|
(2)
+81%
|
1
N/A
|
0
-89%
|
(1)
N/A
|
(1)
-73%
|
(1)
+47%
|
|
Free Cash Flow | |||||||||||||
Free Cash Flow |
(26)
N/A
|
(22)
+14%
|
(18)
+22%
|
(19)
-10%
|
(16)
+20%
|
(11)
+32%
|
(18)
-68%
|
(18)
-3%
|
(12)
+35%
|
(12)
+2%
|
(17)
-45%
|
(23)
-37%
|